As of mid-August 2026, global surveillance by the WHO and CDC shows no novel pathogen meeting pandemic criteria, with confirmed case trends for candidates like H5N1 avian influenza and mpox remaining below sustained human-to-human transmission thresholds. This data, combined with the historical rarity of pandemics and robust early-warning systems, underpins the market's 93.5% implied probability of no new pandemic this year. Traders weigh these verified observations against endemic circulation of known viruses. A realistic shift could occur if a new variant or strain rapidly escalates transmissibility and virulence, prompting official reclassification before year-end.